PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models von Winkler, David G., Faia, Kerrie L., DiNitto, Jonathan P., Ali, Janid A., White, Kerry F., Brophy, Erin E., Pink, Melissa M., Proctor, Jennifer L., Lussier, Jennifer, Martin, Christian M., Hoyt, Jennifer G., Tillotson, Bonnie, Murphy, Erin L., Lim, Alice R., Thomas, Brian D., MacDougall, John R., Ren, Pingda, Liu, Yi, Li, Lian-Sheng, Jessen, Katti A., Fritz, Christian C., Dunbar, Joi L., Porter, James R., Rommel, Christian, Palombella, Vito J., Changelian, Paul S., Kutok, Jeffery L.

Volltext

Single- and Multiple-Dose Pharmacokinetics of Long-acting Injectable Naltrexone von Dunbar, Joi L., Turncliff, Ryan Z., Dong, Qunming, Silverman, Bernard L., Ehrich, Elliot W., Lasseter, Kenneth C.

Volltext

Pharmacokinetics of Long-Acting Naltrexone in Subjects With Mild to Moderate Hepatic Impairment von Turncliff, Ryan Z., Dunbar, Joi L., Dong, Qunming, Silverman, Bernard L., Ehrich, Elliot W., Dilzer, Stacy C., Lasseter, Kenneth C.

Volltext